Parkinson’s Disease On-Demand Morning Therapy

EP. 1: OFF Episodes in Parkinson’s Disease
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD Panelists have a conversation on the definition of OFF episodes in relation to Parkinson’s disease and how common OFF episodes are for patients.

EP. 2: Parkinson’s Disease: Why do OFF Episodes Occur?
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD Expert neurologists discuss why OFF episodes happen and how soon they occur after starting levodopa.

EP. 3: Impact of Parkinson’s Disease OFF Episodes on Quality of Life
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD Key opinion leaders provide insight on how OFF episodes affect patients’ quality of life.

EP. 4: Expected and Unexpected OFF Episodes in Parkinson’s Disease
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD Physicians explain expected versus unexpected OFF episodes and the use of symptom diaries in managing Parkinson’s disease.

EP. 5: Parkinson’s Disease: Evaluating Patients for OFF Episodes
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD A discussion on how patients are evaluated for OFF episodes, by expert neurologists.

EP. 6: Motor and Non-Motor Symptoms in Parkinson’s Disease
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD Panelists describe the motor and non-motor symptoms of Parkinson’s disease, linking symptoms to OFF episodes, and how to educate patients.

EP. 7: The Relationship Between the Gut and Parkinson’s Disease
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD Experts debate the challenges of carbidopa/levodopa, and the relation between levodopa and the gut.

EP. 8: Important Attributes of On-Demand Therapies for Parkinson’s Disease
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD Key opinion leaders explain the important attributes to consider when choosing an on-demand therapy.

EP. 9: When to Use On-Demand Therapies in Parkinson’s Disease
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD Physicians discuss when to add on-demand therapies to Parkinson’s disease management.

EP. 10: Levodopa Inhalation Powder for Parkinson’s Disease
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD Neurologists debate the use of levodopa inhalation powder in managing Parkinson’s disease.

EP. 11: Apomorphine Subcutaneous Injections for Parkinson’s Disease
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD A discussion on the use of apomorphine subcutaneous injections in managing Parkinson’s disease.

EP. 12: Side Effects of Apomorphine Usage in Parkinson’s Disease
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD A panel of experts debate the disadvantages and side effects of apomorphine therapies for Parkinson’s disease.

EP. 13: Sublingual Apomorphine for Parkinson’s Disease
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD Key opinion leaders explain the use of sublingual apomorphine and trimethobenzamide for Parkinson’s disease.

EP. 14: Parkinson’s Disease: Advice for Community Neurologists
ByStuart H. Isaacson, MD, FAAN,Laxman Bahroo, DO,Khashayar Dashtipour, MD,Daniel E. Kremens, MD, JD,William Ondo, MD Expert neurologists provide insight on how to decide on an on-demand therapy for Parkinson’s disease and provide some general advice.